1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Osteoarthritis Medications Market Size 2016-2026 2.1.2 Osteoarthritis Medications Market Size CAGR by Region 2020 VS 2021 VS 2026 2.2 Osteoarthritis Medications Segment by Type 2.2.1 NSAIDs 2.2.2 NSAIDs 2.2.3 Hyaluronic Acid Injection 2.2.4 Others 2.3 Osteoarthritis Medications Market Size by Type 2.3.1 Global Osteoarthritis Medications Market Size CAGR by Type 2.3.2 Global Osteoarthritis Medications Market Size Market Share by Type (2016-2021) 2.4 Osteoarthritis Medications Segment by Application 2.4.1 Hospital Pharmacies 2.4.2 Retail Pharmacies 2.4.3 Online Pharmacies 2.5 Osteoarthritis Medications Market Size by Application 2.5.1 Global Osteoarthritis Medications Market Size CAGR by Application 2.5.2 Global Osteoarthritis Medications Market Size Market Share by Application (2016-2021) 3 Osteoarthritis Medications Market Size by Players 3.1 Osteoarthritis Medications Market Size Market Share by Players 3.1.1 Global Osteoarthritis Medications Revenue by Players (2019-2021E) 3.1.2 Global Osteoarthritis Medications Revenue Market Share by Players (2019-2021E) 3.2 Global Osteoarthritis Medications Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Osteoarthritis Medications by Regions 4.1 Osteoarthritis Medications Market Size by Regions (2016-2021) 4.2 Americas Osteoarthritis Medications Market Size Growth (2016-2021) 4.3 APAC Osteoarthritis Medications Market Size Growth (2016-2021) 4.4 Europe Osteoarthritis Medications Market Size Growth (2016-2021) 4.5 Middle East & Africa Osteoarthritis Medications Market Size Growth (2016-2021) 5 Americas 5.1 Americas Osteoarthritis Medications Market Size by Country (2016-2021) 5.2 Americas Osteoarthritis Medications Market Size by Type (2016-2021) 5.3 Americas Osteoarthritis Medications Market Size by Application (2016-2021) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Osteoarthritis Medications Market Size by Region (2016-2021) 6.2 APAC Osteoarthritis Medications Market Size by Type (2016-2021) 6.3 APAC Osteoarthritis Medications Market Size by Application (2016-2021) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Osteoarthritis Medications by Country (2016-2021) 7.2 Europe Osteoarthritis Medications Market Size by Type (2016-2021) 7.3 Europe Osteoarthritis Medications Market Size by Application (2016-2021) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Osteoarthritis Medications by Region (2016-2021) 8.2 Middle East & Africa Osteoarthritis Medications Market Size by Type (2016-2021) 8.3 Middle East & Africa Osteoarthritis Medications Market Size by Application (2016-2021) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Global Osteoarthritis Medications Market Forecast 10.1 Global Osteoarthritis Medications Forecast by Regions (2021-2026) 10.1.1 Global Osteoarthritis Medications Forecast by Regions (2021-2026) 10.1.2 Americas Osteoarthritis Medications Forecast 10.1.3 APAC Osteoarthritis Medications Forecast 10.1.4 Europe Osteoarthritis Medications Forecast 10.1.5 Middle East & Africa Osteoarthritis Medications Forecast 10.2 Americas Osteoarthritis Medications Forecast by Countries (2021-2026) 10.2.1 United States Osteoarthritis Medications Market Forecast 10.2.2 Canada Osteoarthritis Medications Market Forecast 10.2.3 Mexico Osteoarthritis Medications Market Forecast 10.2.4 Brazil Osteoarthritis Medications Market Forecast 10.3 APAC Osteoarthritis Medications Forecast by Region (2021-2026) 10.3.1 China Osteoarthritis Medications Market Forecast 10.3.2 Japan Osteoarthritis Medications Market Forecast 10.3.3 Korea Osteoarthritis Medications Market Forecast 10.3.4 Southeast Asia Osteoarthritis Medications Market Forecast 10.3.5 India Osteoarthritis Medications Market Forecast 10.3.6 Australia Osteoarthritis Medications Market Forecast 10.4 Europe Osteoarthritis Medications Forecast by Country (2021-2026) 10.4.1 Germany Osteoarthritis Medications Market Forecast 10.4.2 France Osteoarthritis Medications Market Forecast 10.4.3 UK Osteoarthritis Medications Market Forecast 10.4.4 Italy Osteoarthritis Medications Market Forecast 10.4.5 Russia Osteoarthritis Medications Market Forecast 10.5 Middle East & Africa Osteoarthritis Medications Forecast by Region (2021-2026) 10.5.1 Egypt Osteoarthritis Medications Market Forecast 10.5.2 South Africa Osteoarthritis Medications Market Forecast 10.5.3 Israel Osteoarthritis Medications Market Forecast 10.5.4 Turkey Osteoarthritis Medications Market Forecast 10.5.5 GCC Countries Osteoarthritis Medications Market Forecast 10.6 Global Osteoarthritis Medications Forecast by Type (2021-2026) 10.8 Global Osteoarthritis Medications Forecast by Application (2021-2026) 11 Key Players Analysis 11.1 Pfizer 11.1.1 Pfizer Company Information 11.1.2 Pfizer Osteoarthritis Medications Product Offered 11.1.3 Pfizer Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.1.4 Pfizer Main Business Overview 11.1.5 Pfizer Latest Developments 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Information 11.2.2 Johnson & Johnson Osteoarthritis Medications Product Offered 11.2.3 Johnson & Johnson Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.2.4 Johnson & Johnson Main Business Overview 11.2.5 Johnson & Johnson Latest Developments 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Company Information 11.3.2 GlaxoSmithKline Osteoarthritis Medications Product Offered 11.3.3 GlaxoSmithKline Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.3.4 GlaxoSmithKline Main Business Overview 11.3.5 GlaxoSmithKline Latest Developments 11.4 Novartis 11.4.1 Novartis Company Information 11.4.2 Novartis Osteoarthritis Medications Product Offered 11.4.3 Novartis Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.4.4 Novartis Main Business Overview 11.4.5 Novartis Latest Developments 11.5 Bayer 11.5.1 Bayer Company Information 11.5.2 Bayer Osteoarthritis Medications Product Offered 11.5.3 Bayer Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.5.4 Bayer Main Business Overview 11.5.5 Bayer Latest Developments 11.6 Eli Lilly 11.6.1 Eli Lilly Company Information 11.6.2 Eli Lilly Osteoarthritis Medications Product Offered 11.6.3 Eli Lilly Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.6.4 Eli Lilly Main Business Overview 11.6.5 Eli Lilly Latest Developments 11.7 Sanofi 11.7.1 Sanofi Company Information 11.7.2 Sanofi Osteoarthritis Medications Product Offered 11.7.3 Sanofi Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.7.4 Sanofi Main Business Overview 11.7.5 Sanofi Latest Developments 11.8 Horizon Pharma 11.8.1 Horizon Pharma Company Information 11.8.2 Horizon Pharma Osteoarthritis Medications Product Offered 11.8.3 Horizon Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.8.4 Horizon Pharma Main Business Overview 11.8.5 Horizon Pharma Latest Developments 11.9 Abbott 11.9.1 Abbott Company Information 11.9.2 Abbott Osteoarthritis Medications Product Offered 11.9.3 Abbott Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.9.4 Abbott Main Business Overview 11.9.5 Abbott Latest Developments 11.10 Mylan 11.10.1 Mylan Company Information 11.10.2 Mylan Osteoarthritis Medications Product Offered 11.10.3 Mylan Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.10.4 Mylan Main Business Overview 11.10.5 Mylan Latest Developments 11. Daiichi Sankyo 11.11.1 Daiichi Sankyo Company Information 11.11.2 Daiichi Sankyo Osteoarthritis Medications Product Offered 11.11.3 Daiichi Sankyo Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.11.4 Daiichi Sankyo Main Business Overview 11.11.5 Daiichi Sankyo Latest Developments 11.12 TEVA 11.12.1 TEVA Company Information 11.12.2 TEVA Osteoarthritis Medications Product Offered 11.12.3 TEVA Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.12.4 TEVA Main Business Overview 11.12.5 TEVA Latest Developments 11.13 Almatica Pharma 11.13.1 Almatica Pharma Company Information 11.13.2 Almatica Pharma Osteoarthritis Medications Product Offered 11.13.3 Almatica Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.13.4 Almatica Pharma Main Business Overview 11.13.5 Almatica Pharma Latest Developments 11.14 Astellas Pharma 11.14.1 Astellas Pharma Company Information 11.14.2 Astellas Pharma Osteoarthritis Medications Product Offered 11.14.3 Astellas Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.14.4 Astellas Pharma Main Business Overview 11.14.5 Astellas Pharma Latest Developments 11.15 Tide Pharmaceutical 11.15.1 Tide Pharmaceutical Company Information 11.15.2 Tide Pharmaceutical Osteoarthritis Medications Product Offered 11.15.3 Tide Pharmaceutical Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.15.4 Tide Pharmaceutical Main Business Overview 11.15.5 Tide Pharmaceutical Latest Developments 11.16 Iroko Pharmaceuticals 11.16.1 Iroko Pharmaceuticals Company Information 11.16.2 Iroko Pharmaceuticals Osteoarthritis Medications Product Offered 11.16.3 Iroko Pharmaceuticals Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.16.4 Iroko Pharmaceuticals Main Business Overview 11.16.5 Iroko Pharmaceuticals Latest Developments 11.17 Hengrui Pharmaceutical 11.17.1 Hengrui Pharmaceutical Company Information 11.17.2 Hengrui Pharmaceutical Osteoarthritis Medications Product Offered 11.17.3 Hengrui Pharmaceutical Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.17.4 Hengrui Pharmaceutical Main Business Overview 11.17.5 Hengrui Pharmaceutical Latest Developments 11.18 Abiogen Pharma 11.18.1 Abiogen Pharma Company Information 11.18.2 Abiogen Pharma Osteoarthritis Medications Product Offered 11.18.3 Abiogen Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.18.4 Abiogen Pharma Main Business Overview 11.18.5 Abiogen Pharma Latest Developments 11.19 Flexion Therapeutics 11.19.1 Flexion Therapeutics Company Information 11.19.2 Flexion Therapeutics Osteoarthritis Medications Product Offered 11.19.3 Flexion Therapeutics Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.19.4 Flexion Therapeutics Main Business Overview 11.19.5 Flexion Therapeutics Latest Developments 11.20 Anika Therapeutics 11.20.1 Anika Therapeutics Company Information 11.20.2 Anika Therapeutics Osteoarthritis Medications Product Offered 11.20.3 Anika Therapeutics Osteoarthritis Medications Revenue, Gross Margin and Market Share (2019-2021) 11.20.4 Anika Therapeutics Main Business Overview 11.20.5 Anika Therapeutics Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Osteoarthritis Medications Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of NSAIDs Table 3. Major Players of Corticosteroids Table 4. Major Players of Hyaluronic Acid Injection Table 5. Major Players of Others Table 6. Osteoarthritis Medications Market Size CAGR by Type (2020-2026) & ($ Millions) Table 7. Global Osteoarthritis Medications Market Size by Type (2016-2021) & ($ Millions) Table 8. Global Osteoarthritis Medications Market Size Market Share by Type (2016-2021) Table 9. Osteoarthritis Medications Market Size CAGR by Application (2016-2021) & ($ Millions) Table 10. Global Osteoarthritis Medications Market Size by Application (2016-2021) & ($ Millions) Table 11. Global Osteoarthritis Medications Market Size Market Share by Application (2016-2021) Table 12. Global Osteoarthritis Medications Revenue by Players (2019-2021E) & ($ Millions) Table 13. Global Osteoarthritis Medications Revenue Market Share by Players (2019-2021E) Table 14. Osteoarthritis Medications Key Players Head office and Products Offered Table 15. Osteoarthritis Medications Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Osteoarthritis Medications Market Size by Regions 2016-2021 & ($ Millions) Table 19. Global Osteoarthritis Medications Market Size Market Share by Regions 2016-2021 Table 20. Americas Osteoarthritis Medications Market Size by Country (2016-2021) & ($ Millions) Table 21. Americas Osteoarthritis Medications Market Size Market Share by Country (2016-2021) Table 22. Americas Osteoarthritis Medications Market Size by Type (2016-2021) & ($ Millions) Table 23. Americas Osteoarthritis Medications Market Size Market Share by Type (2016-2021) Table 24. Americas Osteoarthritis Medications Market Size by Application (2016-2021) & ($ Millions) Table 25. Americas Osteoarthritis Medications Market Size Market Share by Application (2016-2021) Table 26. APAC Osteoarthritis Medications Market Size by Region (2016-2021) & ($ Millions) Table 27. APAC Osteoarthritis Medications Market Size Market Share by Region (2016-2021) Table 28. APAC Osteoarthritis Medications Market Size by Type (2016-2021) & ($ Millions) Table 29. APAC Osteoarthritis Medications Market Size Market Share by Type (2016-2021) Table 30. APAC Osteoarthritis Medications Market Size by Application (2016-2021) & ($ Millions) Table 31. APAC Osteoarthritis Medications Market Size Market Share by Application (2016-2021) Table 32. Europe Osteoarthritis Medications Market Size by Country (2016-2021) & ($ Millions) Table 33. Europe Osteoarthritis Medications Market Size Market Share by Country (2016-2021) Table 34. Europe Osteoarthritis Medications Market Size by Type (2016-2021) & ($ Millions) Table 35. Europe Osteoarthritis Medications Market Size Market Share by Type (2016-2021) Table 36. Europe Osteoarthritis Medications Market Size by Application (2016-2021) & ($ Millions) Table 37. Europe Osteoarthritis Medications Market Size Market Share by Application (2016-2021) Table 38. Middle East & Africa Osteoarthritis Medications Market Size by Region (2016-2021) & ($ Millions) Table 39. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Region (2016-2021) Table 40. Middle East & Africa Osteoarthritis Medications Market Size by Type (2016-2021) & ($ Millions) Table 41. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Type (2016-2021) Table 42. Middle East & Africa Osteoarthritis Medications Market Size by Application (2016-2021) & ($ Millions) Table 43. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Application (2016-2021) Table 44. Key and Potential Regions of Osteoarthritis Medications Table 45. Key Application and Potential Industries of Osteoarthritis Medications Table 46. Key Challenges of Osteoarthritis Medications Table 47. Key Trends of Osteoarthritis Medications Table 48. Global Osteoarthritis Medications Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 49. Global Osteoarthritis Medications Market Size Market Share Forecast by Regions (2021-2026) Table 50. Global Osteoarthritis Medications Market Size Forecast by Type (2021-2026) & ($ Millions) Table 51. Global Osteoarthritis Medications Market Size Market Share Forecast by Type (2021-2026) Table 52. Global Osteoarthritis Medications Market Size Forecast by Application (2021-2026) & ($ Millions) Table 53. Global Osteoarthritis Medications Market Size Market Share Forecast by Application (2021-2026) Table 54. Pfizer Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 55. Pfizer Osteoarthritis Medications Product Offered Table 56. Pfizer Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 57. Pfizer Main Business Table 58. Pfizer Latest Developments Table 59. Johnson & Johnson Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 60. Johnson & Johnson Osteoarthritis Medications Product Offered Table 61. Johnson & Johnson Main Business Table 62. Johnson & Johnson Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. Johnson & Johnson Latest Developments Table 64. GlaxoSmithKline Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 65. GlaxoSmithKline Osteoarthritis Medications Product Offered Table 66. GlaxoSmithKline Main Business Table 67. GlaxoSmithKline Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 68. GlaxoSmithKline Latest Developments Table 69. Novartis Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 70. Novartis Osteoarthritis Medications Product Offered Table 71. Novartis Main Business Table 72. Novartis Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 73. Novartis Latest Developments Table 74. Bayer Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 75. Bayer Osteoarthritis Medications Product Offered Table 76. Bayer Main Business Table 77. Bayer Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 78. Bayer Latest Developments Table 79. Eli Lilly Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 80. Eli Lilly Osteoarthritis Medications Product Offered Table 81. Eli Lilly Main Business Table 82. Eli Lilly Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 83. Eli Lilly Latest Developments Table 84. Sanofi Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 85. Sanofi Osteoarthritis Medications Product Offered Table 86. Sanofi Main Business Table 87. Sanofi Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 88. Sanofi Latest Developments Table 89. Horizon Pharma Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 90. Horizon Pharma Osteoarthritis Medications Product Offered Table 91. Horizon Pharma Main Business Table 92. Horizon Pharma Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 93. Horizon Pharma Latest Developments Table 94. Abbott Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 95. Abbott Osteoarthritis Medications Product Offered Table 96. Abbott Main Business Table 97. Abbott Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 98. Abbott Latest Developments Table 99. Mylan Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 100. Mylan Osteoarthritis Medications Product Offered Table 101. Mylan Main Business Table 102. Mylan Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 103. Mylan Latest Developments Table 104. Daiichi Sankyo Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 105. Daiichi Sankyo Osteoarthritis Medications Product Offered Table 106. Daiichi Sankyo Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 107. Daiichi Sankyo Main Business Table 108. Daiichi Sankyo Latest Developments Table 109. TEVA Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 110. TEVA Osteoarthritis Medications Product Offered Table 111. TEVA Main Business Table 112. TEVA Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 113. TEVA Latest Developments Table 114. Almatica Pharma Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 115. Almatica Pharma Osteoarthritis Medications Product Offered Table 116. Almatica Pharma Main Business Table 117. Almatica Pharma Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 118. Almatica Pharma Latest Developments Table 119. Astellas Pharma Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 120. Astellas Pharma Osteoarthritis Medications Product Offered Table 121. Astellas Pharma Main Business Table 122. Astellas Pharma Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 123. Astellas Pharma Latest Developments Table 124. Tide Pharmaceutical Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 125. Tide Pharmaceutical Osteoarthritis Medications Product Offered Table 126. Tide Pharmaceutical Main Business Table 127. Tide Pharmaceutical Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 128. Tide Pharmaceutical Latest Developments Table 129. Iroko Pharmaceuticals Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 130. Iroko Pharmaceuticals Osteoarthritis Medications Product Offered Table 131. Iroko Pharmaceuticals Main Business Table 132. Iroko Pharmaceuticals Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 133. Iroko Pharmaceuticals Latest Developments Table 134. Hengrui Pharmaceutical Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 135. Hengrui Pharmaceutical Osteoarthritis Medications Product Offered Table 136. Hengrui Pharmaceutical Main Business Table 137. Hengrui Pharmaceutical Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 138. Hengrui Pharmaceutical Latest Developments Table 139. Abiogen Pharma Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 140. Abiogen Pharma Osteoarthritis Medications Product Offered Table 141. Abiogen Pharma Main Business Table 142. Abiogen Pharma Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 143. Abiogen Pharma Latest Developments Table 144. Flexion Therapeutics Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 145. Flexion Therapeutics Osteoarthritis Medications Product Offered Table 146. Flexion Therapeutics Main Business Table 147. Flexion Therapeutics Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 148. Flexion Therapeutics Latest Developments Table 149. Anika Therapeutics Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors Table 150. Anika Therapeutics Osteoarthritis Medications Product Offered Table 151. Anika Therapeutics Main Business Table 152. Anika Therapeutics Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 153. Anika Therapeutics Latest Developments List of Figures Figure 1. Osteoarthritis Medications Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Osteoarthritis Medications Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Osteoarthritis Medications Market Size Market Share by Type in 2020 Figure 7. Osteoarthritis Medications in Hospital Pharmacies Figure 8. Global Osteoarthritis Medications Market: Hospital Pharmacies (2016-2021) & ($ Millions) Figure 9. Osteoarthritis Medications in Retail Pharmacies Figure 10. Global Osteoarthritis Medications Market: Retail Pharmacies (2016-2021) & ($ Millions) Figure 11. Osteoarthritis Medications in Online Pharmacies Figure 12. Global Osteoarthritis Medications Market: Online Pharmacies (2016-2021) & ($ Millions) Figure 13. Global Osteoarthritis Medications Market Size Market Share by Application in 2020 Figure 14. Global Osteoarthritis Medications Revenue Market Share by Player in 2020 Figure 15. Global Osteoarthritis Medications Market Size Market Share by Regions (2016-2021) Figure 16. Americas Osteoarthritis Medications Market Size 2016-2021 ($ Millions) Figure 17. APAC Osteoarthritis Medications Market Size 2016-2021 ($ Millions) Figure 18. Europe Osteoarthritis Medications Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Osteoarthritis Medications Market Size 2016-2021 ($ Millions) Figure 20. Americas Osteoarthritis Medications Market Size Market Share by Country in 2020 Figure 21. Americas Osteoarthritis Medications Market Size Market Share by Type in 2020 Figure 22. Americas Osteoarthritis Medications Market Size Market Share by Application in 2020 Figure 23. United States Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Osteoarthritis Medications Market Size Market Share by Regions in 2020 Figure 27. APAC Osteoarthritis Medications Market Size Market Share by Type in 2020 Figure 28. APAC Osteoarthritis Medications Market Size Market Share by Application in 2020 Figure 29. China Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 33. India Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Osteoarthritis Medications Market Size Market Share by Country in 2020 Figure 36. Europe Osteoarthritis Medications Market Size Market Share by Type in 2020 Figure 37. Europe Osteoarthritis Medications Market Size Market Share by Application in 2020 Figure 38. Germany Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 39. France Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Application in 2020 Figure 46. Egypt Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Osteoarthritis Medications Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 52. APAC Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 53. Europe Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 55. United States Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 56. Canada Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 57. Mexico Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 58. Brazil Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 59. China Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 60. Japan Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 61. Korea Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 63. India Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 64. Australia Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 65. Germany Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 66. France Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 67. UK Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 68. Italy Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 69. Russia Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 70. Spain Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 71. Egypt Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 72. South Africa Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 73. Israel Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 74. Turkey Osteoarthritis Medications Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Osteoarthritis Medications Market Size 2021-2026 ($ Millions)